Company intelligence / Profile preview

Preceptis Medical

Golden Valley, Minnesota, United Stateshummingbirdeartubes.com ↗

Ownership: Private
Development stage: Phase 2

Overview

The Hummingbird® Tympanostomy Tube System (TTS) by Preceptis Medical enables safe, efficient office-based ear tube placement in children as young as six months old. It eliminates the need for general anesthesia and operating room use. Clinical studies report a high success rate (~98%) with rapid recovery and strong parent/ENT satisfaction. The system has received expanded FDA clearance and a new CMS reimbursement code to support broader adoption.

Therapeutic areas: OtherInfectious Diseases
Modalities: DeviceSurgical instrument (specifically for tympanostomy tube placement)
Industry: Surgical Medical Devices

Drug pipeline

1 asset

DurAVR THV system

Phase 2

Indications: Aortic valve stenosis

Partnerships

None publicly disclosed

Beyond the preview

Go deeper on Preceptis Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Preceptis Medical.

Explore the full profile